Iminoral 100 Capsule contains Ciclosporin 100 mg, an immunosuppressive agent primarily used to prevent organ transplant rejection and to treat various autoimmune disorders. Ciclosporin acts by selectively inhibiting the activation of T-lymphocytes, thereby suppressing the immune response. This mechanism is crucial in reducing the risk of graft rejection following kidney, liver, or heart transplantation. Additionally, Iminoral is indicated in the management of severe rheumatoid arthritis and psoriasis unresponsive to conventional therapies. The capsule formulation ensures precise dosing and facilitates patient compliance. Due to its potent immunosuppressive effects, careful monitoring of blood levels, renal function, and liver enzymes is essential during therapy to minimize adverse effects such as nephrotoxicity, hypertension, and increased susceptibility to infections. Dose adjustments may be necessary based on therapeutic response and tolerability. Patients should be advised to avoid concurrent use of nephrotoxic drugs and grapefruit juice, which can alter Ciclosporin metabolism. Iminoral should be administered under strict medical supervision with regular follow-up assessments to optimize therapeutic outcomes and ensure patient safety. This medication is contraindicated in patients with hypersensitivity to Ciclosporin or those with uncontrolled infections.